Li Zhou

Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients

Bixia Tang, Xieqiao Yan, Xinan Sheng et al. · Journal of Hematology & Oncology · 2019 · 188 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients

Bin Lian, C-L. Cui, Li Zhou et al. · Annals of Oncology · 2016 · 170 citations

Medicine, Oncology, Surgery +16

Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G₄ Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial

Xinan Sheng, Xieqiao Yan, Zhihong Chi et al. · Journal of Clinical Oncology · 2019 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy

Haixia Long, Qingzhu Jia, Liuyang Wang et al. · Cancer Cell · 2022 · 142 citations

Medicine, Immunology, Oncology +12

<i>MAPK</i> Pathway and <i>TERT</i> Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases

Xue Bai, Yan Kong, Zhihong Chi et al. · Clinical Cancer Research · 2017 · 114 citations

Medicine, Molecular Genetics, Oncology +17